massive cerebral infarction
Conditions
Interventions
control group :Routine treatment of cerebral infarction (anti-platelet, regulating blood lipid, improving circulation, etc.)
experimental group:Adequate dosage and course of Dexborneol Concentrated Solution for Injection were used during hospitalization
Sponsors
Longyan First Hospital Affiliated to Fujian Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients with new cerebral infarction who were hospitalized in our hospital and admitted to the hospital within 48 hours of onset; 2. Aged between 18-80 years; 3. Patients with cerebral infarction who have been diagnosed with cerebral infarction by head CT or MRI and meet the diagnostic criteria for large-area cerebral infarction (The diagnostic criteria for large-area cerebral infarction: the infarction of the cerebral hemisphere exceeds one lobe, and the diameter of the infarction measured by cranial CT or MRI is greater than 5 cm).
Exclusion criteria
Exclusion criteria: 1. Combined with severe organ failure (heart, liver and kidney failure); 2. Patients with severe respiratory infection and other organ infections; 3. Patients with moderate or higher anemia or coagulation dysfunction or other serious blood system diseases; 4. Patients with severe endocrine diseases; 5. Patients with autoimmune system diseases; 6. Patients with malignant tumor; 7. Patients or their guardians are unwilling to participate in the project.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IL1-ß;IL-4;IL-6;TNF-a;Hypersensitive C-reactive protein; | — |
Countries
China
Contacts
Public ContactHu Xiaohong
Longyan First Hospital Affiliated to Fujian Medical University
Outcome results
None listed